 Drug Delivery Systems
"Drug Delivery Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
| Descriptor ID |
D016503
|
| MeSH Number(s) |
E02.319.300
|
| Concept/Terms |
Drug Delivery Systems- Drug Delivery Systems
- Delivery System, Drug
- Delivery Systems, Drug
- Drug Delivery System
- System, Drug Delivery
- Systems, Drug Delivery
- Drug Targeting
- Drug Targetings
- Targeting, Drug
- Targetings, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Delivery Systems".
Below are MeSH descriptors whose meaning is more specific than "Drug Delivery Systems".
This graph shows the total number of publications written about "Drug Delivery Systems" by people in this website by year, and whether "Drug Delivery Systems" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1998 | 3 | 0 | 3 | | 1999 | 2 | 1 | 3 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 1 | 2 | | 2002 | 6 | 3 | 9 | | 2003 | 4 | 2 | 6 | | 2004 | 3 | 3 | 6 | | 2005 | 4 | 2 | 6 | | 2006 | 3 | 4 | 7 | | 2007 | 4 | 3 | 7 | | 2008 | 4 | 8 | 12 | | 2009 | 8 | 14 | 22 | | 2010 | 18 | 5 | 23 | | 2011 | 7 | 5 | 12 | | 2012 | 7 | 5 | 12 | | 2013 | 7 | 4 | 11 | | 2014 | 9 | 3 | 12 | | 2015 | 14 | 7 | 21 | | 2016 | 3 | 6 | 9 | | 2017 | 9 | 4 | 13 | | 2018 | 3 | 8 | 11 | | 2019 | 13 | 4 | 17 | | 2020 | 5 | 7 | 12 | | 2021 | 8 | 9 | 17 | | 2022 | 3 | 2 | 5 | | 2023 | 2 | 5 | 7 | | 2024 | 2 | 7 | 9 | | 2025 | 5 | 5 | 10 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Delivery Systems" by people in Profiles.
-
Patil MA, Matter BA, Santana C, Kompella UB. Interspecies scaling of suprachoroidal drug delivery using ocular geometry and drug physicochemical properties. Sci Rep. 2026 Jan 16; 16(1):4502.
-
Chauhan A, Hazra S, Matter B, Sharma PK, George S, Dey A, Nagaraju Kumara B, Kompella UB. Cysteamine-eluting contact lenses: integrating in vitro, in vivo, and in silico approaches for ocular drug delivery. Int J Pharm. 2026 Feb 10; 690:126528.
-
Kumari N, Panja S, Kumar B, Ahmad R, Kollala SS, Siddhanta K, Islam F, Joshi V, Talmon GA, Murry DJ, Singh AB, Oupický D. Reactive Oxygen Species-Responsive Polymeric Chloroquine Nanogel for Targeted Oral Therapy of Ulcerative Colitis. ACS Appl Mater Interfaces. 2025 Sep 10; 17(36):50443-50463.
-
Murray AM, Swingle KL, Mitchell MJ. Engineering Nanoparticles for Gynecologic Cancer Therapy. ACS Nano. 2025 Sep 02; 19(34):30758-30785.
-
Salehi Moghaddam A, Bahrami M, Sarikhani E, Tutar R, Ertas YN, Tamimi F, Hedayatnia A, Jugie C, Savoji H, Qureshi AT, Rizwan M, Maduka CV, Ashammakhi N. Engineering the Immune Response to Biomaterials. Adv Sci (Weinh). 2025 May; 12(19):e2414724.
-
Tang S, Han EL, Mitchell MJ. Peptide-functionalized nanoparticles for brain-targeted therapeutics. Drug Deliv Transl Res. 2026 Mar; 16(3):741-760.
-
Peeler DJ, Sun R, Kütahya C, Peschke P, Zhou K, Brachi G, Yeow J, Rifaie-Graham O, Wojciechowski JP, Fernandez Debets TFF, LaLone V, Song X, Polra K, McKay PF, Tregoning JS, Shattock RJ, Stevens MM. Nanoscale Biodegradable Printing for Designed Tuneability of Vaccine Delivery Kinetics. Adv Mater. 2025 Apr; 37(15):e2417290.
-
Escobedo HD, Zawadzki N, Till JKA, Vazquez-Torres A, Wang G, Simberg D, Orlicky DJ, Johnson J, Guess MK, Nair DP, Schurr MJ. Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections. Nanomedicine. 2025 04; 65:102812.
-
Padilla MS, Mrksich K, Wang Y, Haley RM, Li JJ, Han EL, El-Mayta R, Kim EH, Dias S, Gong N, Teerdhala SV, Han X, Chowdhary V, Xue L, Siddiqui Z, Yamagata HM, Kim D, Yoon IC, Wilson JM, Radhakrishnan R, Mitchell MJ. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering. Nat Commun. 2025 Jan 24; 16(1):996.
-
Collins J, Farnsworth NL. Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. Diabetologia. 2025 Apr; 68(4):692-703.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|